AOTI to Participate at Jefferies 2018 London Healthcare Conference and Present at the 3rd Annual INV€$TIVAL Showcase in Partnership with Jefferies

by Mike Hughes | Oct 26, 2018 | Press

OCEANSIDE, Calif., Oct. 18, 2018 /PRNewswire/ — AOTI Inc. announced today that it will participate at Jefferies 2018 London Healthcare Conference, being held on November 14 and 15, 2018 in London, United Kingdom. Now in its ninth year, the Jefferies conference...

TWO2 Randomized Controlled Trial Chosen as One of the Best Abstracts Presented at the Leading Diabetic Foot Global Conference

by Mike Hughes | Oct 11, 2018 | Press

OCEANSIDE, Calif., Oct. 11, 2018 /PRNewswire/ — AOTI Inc. announced today that expanded results from its recently concluded Randomized Controlled Trial (RCT) demonstrating the efficacy of its patented multi-modality Topical Wound Oxygen (TWO2) homecare therapy...

Opening of New Manufacturing Facility to Meet Expanding Demand for Topical Wound Oxygen (TWO2) Therapy Devices

by Mike Hughes | Aug 8, 2018 | Press

We are delighted to invest in this new facility that will allow us to more effectively ramp up production of our unique multi-modality wound care therapy product line to meet our continually expanding supply needs,” stated Dr. Mike Griffiths, Chief Executive Officer and President of AOTI.

Breakthrough Randomized Controlled Trial Demonstrating TWO2 Efficacy in Healing Diabetic Foot Ulcers unveiled at the American Diabetes Association 78th Scientific Sessions Conference

by Mike Hughes | Jun 26, 2018 | Press

This breakthrough study unequivocally demonstrates at the highest scientific level the efficacy of Cyclical Pressure Topical Wound Oxygen Therapy in healing Diabetic Foot Ulcers” stated Dr. Robert Frykberg, the Chief Principle Investigator of the study.

Unprecedented Study Results Demonstrating Topical Wound Oxygen Effectiveness Presented at Major Wound Care Conferences

by Mike Hughes | May 22, 2018 | Press

The study was a two-year retrospective review of 71 patients with a total of 115 wounds treated by a Veterans Affairs hospital in Chicago that prescribed cyclical pressurized TWO2 therapy for use at home.

AOTI Inc. Announces New York City Office Grand Opening

by Mike Hughes | Aug 15, 2017 | Press

AOTI Inc. announced today that its fully owned USA-operating subsidiary, Advanced Oxygen Therapy Inc., has recently opened a New York City Office in Yonkers, New York to support the ever-increasing usage of its unique Topical Wound Oxygen (TWO2) homecare therapy. This new East Coast location has also been approved by the Accreditation Commission for Health Care (ACHC) under the company’s DMEPOS accreditation for Home/Durable Medical Equipment Services.